Review Article
Volume 9 Issue 4 - 2020
Bronchiectasis for Thoracic Surgeon: Classification, Etiologies, Diagnosis and Management
Harmouchi Hicham1*, M Serraj1,2, Lakranbi Marouane1,3, Ouadnouni Yassine1,3and Smahi Mohamed1,3
1Department of Thoracic Surgery, CHU Hassan II of Fez, Morocco
2Department of Pneumology, CHU Hassan II of Fez, Morocco
3Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdallah University, Fez, Morocco
*Corresponding Author: Harmouchi Hicham, Thoracic Surgery Department, CHU Hassan II of Fez, Morocco.
Received: January 18, 2020; Published: March 16, 2020




Abstract

Bronchiectasis is an abnormal and irreversible dilatation of the bronchi. It is classified into two groups: localized and diffuse bronchiectasis. Local causes such as endobronchial process, foreign body or compressive lymph node are responsible of localized bronchiectasis. Cystic fibrosis, ciliary dyskinesia and immunity deficiency are the main etiologies for diffuse bronchiectasis. The medical treatment is indicated in all cases. Surgery is associated to well outcomes in localized forms and improve the daily life of patient in the diffuse forms when medical treatment is insufficient.

Keywords: Bronchiectasis; Surgery; Anatomical Resection; Complication

References

  1. Gillman MW. “Developmental origins of health and disease”. The New England Journal of Medicine 353.17 (2005): 1848-1850.
  2. Ice B., et al. “Sleep-disordered breathing and upper airway size in pregnancy and post-partum”. European Respiratory Journal 27.2 (2006): 321-327. 
  3. Pien GW., et al. “Changes in symptoms of sleep-disordered breathing during pregnancy”. Sleep 28.10 (2005): 1299-1305.
  4. Izci B., et al. “The upper airway in pregnancy and pre-eclampsia”. American Journal of Respiratory and Critical Care Medicine 167.2 (2003):137-140. 
  5. Bourjeily G., et al. “Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing”. European Respiratory Journal 36.4 (2010): 849-855.
  6. Franklin KA., et al. “Snoring, pregnancy-induced hypertension, and growth retardation of the fetus”. Chest 117.1 (2000): 137-141. 
  7. Reid J., et al. “Can gestational hypertension be modified by treating nocturnal airflow limitation?” Journal of Clinical Sleep Medicine 9.4 (2013): 311-317. 
  8. Pilkington S., et al. “Increase in Mallampati score during pregnancy”. British Journal of Anaesthesia 74.6 (1995): 638-642.
  9. Pamidi S., et al. “Maternal sleep-disordered breathing and adverse pregnancy outcomes: a systematic review and metaanalysis”. American Journal of Obstetrics and Gynecology 210.1 (2014): e1-52.
  10. Facco FL., et al. “Association Between Sleep-Disordered Breathing and Hypertensive Disorders of Pregnancy and Gestational Diabetes Mellitus”. Obstetrics and Gynecology 129 (2017): 31.
  11. Pien GW and Schwab RJ. “Sleep disorders during pregnancy”. Sleep 27 (2004): 1405.
  12. Bixler EO., et al. “Prevalence of sleep-disordered breathing in women: effects of gender”. American Journal of Respiratory and Critical Care Medicine 163 (2001): 608.
  13. Young T., et al. “Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study”. American Journal of Respiratory and Critical Care Medicine 167 (2003): 1181.
  14. Young T., et al. “The occurrence of sleep-disordered breathing among middle-aged adults”. The New England Journal of Medicine 328 (1993): 1230.
  15. Garvey JF., et al. “Epidemiological aspects of obstructive sleep apnea”. Journal of Thoracic Disease 7.5 (2015): 920-929.
  16. Spence DL., et al. “Association of obstructive sleep apnea with adverse pregnancy-related outcomes in military hospitals”. European Journal of Obstetrics and Gynecology and Reproductive Biology 210 (2017): 166-172. 
  17. Louis JM., et al. “Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009”. Sleep 37.5 (2014): 843-849.
  18. Facco FL., et al. “Sleep disturbances in pregnancy”. Obstetrics and Gynecology 115.1 (2010): 77-83. 
  19. Maasilta P., et al. “Sleep-related disordered breathing during pregnancy in obese women”. Chest 120.5 (2001): 1448-1454.
  20. National Health Survey. MSCBS-INE (2017). 
  21. Izci B., et al. “Sleep-disordered breathing and upper airway size in pregnancy and post-partum”. European Respiratory Journal 27 (2006): 321.
  22. Facco FL., et al. “Sleep disturbances in pregnancy”. Obstetrics and Gynecology 115 (2010): 77.
  23. Kapsimalis F and Kryger MH. “Gender and obstructive sleep apnea syndrome, part 1: Clinical features”. Sleep 25 (2002): 412.
  24. Sedov ID., et al. “Sleep quality during pregnancy: A meta-analysis”. Sleep Medicine Reviews 38 (2018): 168-176.
  25. Mindell JA., et al. “Sleep patterns and sleep disturbances across pregnancy”. Sleep Medicine 16.4 (2015): 483-488.
  26. Antony KM., et al. “Association of adverse perinatal outcomes with screening measures of obstructive sleep apnea”. Journal of Perinatology 34.6 (2014): 441-448.
  27. Wilson DL., et al. “Sleep-disordered breathing in hypertensive disorders of pregnancy: a BMI-matched study”. Journal of Sleep Research 27.5 (2018): e12656.
  28. Tantrakul V., et al. “Screening of obstructive sleep apnea during pregnancy: differences in predictive values of questionnaires across trimesters”. Journal of Clinical Sleep Medicine 11.2 (2015): 157-163.
  29. Tantrakul V., et al. “Performance of screening questionnaires for obstructive sleep apnea during pregnancy: A systematic review and meta-analysis”. Sleep Medicine Reviews 36 (2017): 96-106.
  30. Fung AM., et al. “Effects of maternal obstructive sleep apnoea on fetal growth: a prospective cohort study”. PLoS One 8.7 (2013): e68057.
  31. Luo J., et al. “STOP-Bang questionnaire is superior to Epworth sleepiness scales, Berlin questionnaire, and STOP questionnaire in screening obstructive sleep apnea hypopnea syndrome patients”. Chinese Medical Journal 127.17 (2014): 3065-3070. 
  32. Izci-Balserak B., et al. “A ScreeningAlgorithm for Obstructive Sleep Apnea in Pregnancy”. Annals of the American Thoracic Society 16.10 (2019):1286-1294. 
  33. Cooksey JA and Balachandran JS. “Portable Monitoring for the Diagnosis of OSA”. Chest 149.4 (2016): 1074-1081.
  34. Kuna ST., et al. “Noninferiority of functional outcome in ambulatory management of obstructive sleep apnea”. American Journal of Respiratory and Critical Care Medicine 183.9 (2011): 1238-1244.
  35. Aurora RN., et al. “Agreement Between Results of Home Sleep Testing for Obstructive Sleep Apnea with and Without a Sleep Specialist”. The American Journal of Medicine 129.7 (2016): 725-730.
  36. Kapur VK., et al. “Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline”. Journal of Clinical Sleep Medicine 13 (2017): 479.
  37. O'Brien LM., et al. “Validation of Watch-PAT-200 against polysomnography during pregnancy”. Journal of Clinical Sleep Medicine 8.3 (2012): 287-294.
  38. Bourjeily G., et al. “Obstructive sleep apnea in pregnancy is associated with adverse maternal outcomes: a national cohort”. Sleep Medicine 38 (2017): 50-57.
  39. Li L., et al. “Association between Sleep-Disordered Breathing during Pregnancy and Maternal and Fetal Outcomes: An Updated Systematic Review and Meta-Analysis”. Frontiers in Neurology 9 (2018): 91.
  40. Franklin KA., et al. “Snoring, pregnancy-induced hypertension, and growth retardation of the fetus”. Chest 117 (2000): 137.
  41. Loube DI., et al. “Self-reported snoring in pregnancy. Association with fetal outcome”. Chest 109 (1996): 885.
  42. Facco FL., et al. “Association Between Sleep-Disordered Breathing and Hypertensive Disorders of. Pregnancy and Gestational Diabetes Mellitus”. Obstetrics and Gynecology 129.1 (2017): 31-41. 
  43. Truong KK and Guilleminault C. “Sleep disordered breathing in pregnant women: maternal and fetal risk, treatment considerations, and future perspectives”. Expert Review of Respiratory Medicine 12.3 (2018):177-189. 
  44. O'Brien LM., et al. “Hypertension, snoring, and obstructive sleep apnoea during pregnancy: a cohort study”. British Journal of Obstetrics and Gynaecology 121.13 (2014): 1685-1693.
  45. Gozal D and Kheirandish-Gozal L. “Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more”. American Journal of Respiratory and Critical Care Medicine 177 (2008): 369.
  46. Edwards N., et al. “Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia”. American Journal of Respiratory and Critical Care Medicine 162 (2000): 252.
  47. Ursavas A., et al. “Self-reported snoring, maternal obesity and neck circumference as risk factors for pregnancy-induced hypertension and preeclampsia”. Respiration 76.1 (2008): 33-39.
  48. Salameh M., et al. “Snoring and markers of fetal and placental wellbeing”. Clinica Chimica Acta 485 (2018): 139-143. 
  49. Dave F., et al. “Obstructive sleep apnoea in multiple pregnancy”. The Australian and New Zealand Journal of Obstetrics and Gynaecology 59.3 (2019): 341-345.
  50. Chen YH., et al. “Obstructive sleep apnea and the risk of adverse pregnancy outcomes”. American Journal of Obstetrics and Gynecology 206 (2012): 136.
  51. Brown NT., et al. “The intrapartum and perinatal risks of sleep-disordered breathing in pregnancy: a systematic review and metaanalysis”. American Journal of Obstetrics and Gynecology 219.2 (2018): 147-161.
  52. Kneitel AW., et al. “Effects of maternal obstructive sleep apnea on fetal growth: a case-control study”. Journal of Perinatology 38.8 (2018): 982-988.
  53. Chen YH., et al. “Obstructive sleep apnea and the risk of adverse pregnancy outcomes”. American Journal of Obstetrics and Gynecology 206.2 (2012): e5. 
  54. Izci-Balserak B and Pien GW. “Sleep-disordered breathing and pregnancy: potential mechanisms and evidence for maternal and fetal morbidity”. Current Opinion in Pulmonary Medicine 16.6 (2010): 574-582.
  55. Pamidi S., et al. “Maternal sleep-disordered breathing and the risk of delivering small for gestational age infants: a prospective cohort study”. Thorax 71.8 (2016): 719-725. 
  56. Telerant A., et al. “Mild Maternal Obstructive Sleep Apnea in Non-obese Pregnant Women and Accelerated Fetal Growth”. Scientific Reports 8.1 (2018): 10768. 
  57. Khalyfa A., et al. “Late gestational intermittent hypoxia induces metabolic and epigenetic changes in male adult offspring mice”. The Journal of Physiology 595.8 (2017): 2551-2568. 
  58. Kidron D., et al. “The effect of maternal obstructive sleep apnea on the placenta”. Sleep 42.6 (2019).
  59. Olivarez SA., et al. “Prospective trial on obstructive sleep apnea in pregnancy and fetal heart rate monitoring”. American Journal of Obstetrics and Gynecology 202 (2010): 5521.
  60. Brown NT., et al. “The intrapartum and perinatal risks of sleep-disordered breathing in pregnancy: a systematic review and metaanalysis”. American Journal of Obstetrics and Gynecology 219 (2018): 147.
  61. Salihu HM., et al. “Association between maternal symptoms of sleep disordered breathing and fetal telomere length”. Sleep 38.4 (2015): 559-566.
  62. Savolainen K., et al. “The history of sleep apnea is associated with shorter leukocyte telomere length: the Helsinki Birth Cohort Study”. Sleep Medicine 15.2 (2014): 209-212.
  63. Krawczak EM., et al. “Do changes in subjective sleep and biological rhythms predict worsening in postpartum depressive symptoms? A prospective study across the perinatal period”. Archives of Women's Mental Health 19.4 (2016): 591-598.
  64. Vizzini L., et al. “Maternal anxiety, depression and sleep disorders before and during pregnancy, and preschool ADHD symptoms in the NINFEA birth cohort study”. Epidemiology and Psychiatric Sciences 28.5 (2019): 521-531.
  65. https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/70201a-eng.php (Accessed on July 15, 2019).
  66. Chirakalwasan N., et al. “Continuous Positive Airway Pressure Therapy in Gestational Diabetes With Obstructive Sleep Apnea: A Randomized Controlled Trial”. Journal of Clinical Sleep Medicine 14.3 (2018): 327-336. 
  67. Martínez-Ceron E., et al. “Effects of continuous positive airway pressure treatment on glucose metabolism in patients with obstructive sleep apnea”. Sleep Medicine Reviews 25 (2016): 121-130.
  68. Ong JC and Crawford MR. “Insomnia and Obstructive Sleep Apnea”. Sleep Medicine Clinics 8.3 (2013): 389-398.
  69. American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. “Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea”. Anesthesiology 120.2 (2014): 268-286. 
Citation: Harmouchi Hicham., et al. “Bronchiectasis for Thoracic Surgeon: Classification, Etiologies, Diagnosis and Management”. EC Pulmonology and Respiratory Medicine 9.4 (2020): 31-37.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for April Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the May issue of respective journals. Submissions are accepted on/before April 14, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk